WuXi Biologics wins ABL Bio contract for bispecific antibodies
South Korean biotech ABL Bio has selected WuXi Biologics to develop and manufacture up to eight bispecific antibodies for the clinic.
Archives for November 29, 2018
DIA BIOSIMILARS CONFERENCE
Insight: The role of the nurse in biosimilar uptake
Nurses can take the lead when ‘making the switch’ between an originator and biosimilar medicine, says nurse practitioner Hanneke Voorneveld-Nieuwenhuis.